首页|基于A-to-I RNA编辑的列线图预测肺腺癌患者的总生存期

基于A-to-I RNA编辑的列线图预测肺腺癌患者的总生存期

扫码查看
目的 应用ATIRE建立预后模型预测LUAD患者的总生存期(OS),并根据ATIRE风险评分和临床病理特征构建预测LUAD患者OS的列线图.方法 从癌症基因组图谱(TCGA)数据库中下载LUAD患者的RNA编辑数据、转录组数据及相应的临床资料,探讨与生存相关的ATIRE.患者随机分为建模组(n=287)与验证组(n=192),通过单因素COX风险回归、套索算法(Lasso)回归以及多元逐步COX风险回归分析,识别与生存相关的ATIRE位点并建立ATIRE风险评分.构建列线图预测LUAD患者的OS.分析RNA编辑与基因表达的相关性以及ATIRE对转录组表达的影响.结果 确定了4个位点作为最优预后位点,ADAM19|chr5:156904952、CWF19L1|chr10:101992267、FOXK1|chr7:4809281、CPT1A|chr11:68523468.建立风险评分,高风险组的OS在建模组、验证组和所有患者组均明显降低.列线图在预测LUAD的OS方面表现良好.结论 基于AITRE模型可作为预测LUAD生存率的新工具.
Objective To use A-to-I RNA editing(ATIRE)to establish a prediction model to predict the overall survival(OS)of lung adenocarcinoma(LUAD)patients,and to construct a nomogram for predicting LUAD OS according to ATIRE riskscore and clinicopathological characteristics.Methods The RNA editing data,transcriptome data and corresponding clinical data of LUAD patients were downloaded from the cancer genome atlas(TCGA)database to explore the survival-related ATIRE.Patients were randomly divided into the training set(n=287)and the validation set(n=192)to identify survival-related ATIRE sites and generate ATIRE riskscore through univariate COX hazard regression,Lasso regression,and multivariate stepwise COX hazard regression analyses.A nomogram was constructed to predict the OS of LUAD patients.Analyzed the correlation between RNA editing and gene expression and the effect of ATIRE on transcriptome expression.Results Four ATIRE loci(ADAM19|chr5:156904952,CWF19L1|chr10:101992267,FOXK1|chr7:4809281,CPT1A|chr11:68523468)were identified to generate a riskscore,and OS in the high-risk group was significantly lower for the training set,the validation set,and all patient groups.Nomograms performed well in predicting OS rates in LUAD.Conclusion The AITRE-based model can be used as a new tool for predicting LUAD survival.

Lung adenocarcinomaThe cancer genome atlasA-to-I RNA editingOverall survivalNomogram

朱鑫杰、包德荣、徐玉芬

展开 >

314000 浙江中医药大学嘉兴学院联培基地

肺腺癌 癌症基因组图谱 A-to-I RNA编辑 总生存期 列线图

嘉兴市科技计划项目

2019AY32030

2024

浙江临床医学
浙江中医药大学 浙江省科普作家协会医学卫生委员会

浙江临床医学

影响因子:0.52
ISSN:1008-7664
年,卷(期):2024.26(1)
  • 27